Study objectives
death, Toxicity
ADVERSE REACTIONS, ADVERSE EVENT, SECONDARY
The primary objective was to compare freedom from transplantation (treatment)-related mortality (freedom from TRM), defined as death from any transplantation (treatment)-related cause from start of conditioning treatment (Day -7) until Day +100 after allogeneic HSCT. Toxicity was documented using the Common Terminology Criteria for Adverse Events (CTCAE, version 4.03) until Day +100 and serious adverse reactions until the end of follow-up.Comparative exploratory analyses also included engraftment, primary or secondary graft failure, complete ( ≥ 95%) or mixed ( ≥ 20%) donor-type chimerism, transplantation-related mortality (TRM), overall survival (OS), acute [